CRISPR

CRISPR2-nr3c1

ID
ZDB-CRISPR-190529-1
Name
CRISPR2-nr3c1
Previous Names
None
Target
Sequence
5' - CTCCATCTTTGGCGACGA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ca401 nr3c1
Expression
Gene expression in Wild Types + CRISPR2-nr3c1
No data available
Phenotype
Phenotype resulting from CRISPR2-nr3c1
No data available
Phenotype of all Fish created by or utilizing CRISPR2-nr3c1
Phenotype Fish Conditions Figures
whole organism pomca expression increased amount, abnormal nr3c1ca401/ca401 control Fig. 2 from Faught et al., 2018
male organism increased weight, abnormal nr3c1ca401/ca401 standard conditions Fig. 1 from Faught et al., 2019
whole organism trim63b expression decreased amount, abnormal nr3c1ca401/ca401 fasting Fig. 6 from Faught et al., 2019
whole organism protein increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 1 from Faught et al., 2019
muscle L-lysine increased amount, abnormal nr3c1ca401/ca401 control Fig. 7 from Faught et al., 2019
whole organism hsd11b2 expression increased amount, abnormal nr3c1ca401/ca401 control Fig. 2 from Faught et al., 2018
hexokinase activity increased occurrence, abnormal nr3c1ca401/ca401 control Fig. 4 from Faught et al., 2019
swimming behavior increased process quality, abnormal nr3c1ca401/ca401 mechanical stress Fig. 6 from Faught et al., 2021
whole organism lipid increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 1 from Faught et al., 2019
muscle L-threonine increased amount, abnormal nr3c1ca401/ca401 fasting Fig. 7 from Faught et al., 2019
whole organism fasn expression increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 3 from Faught et al., 2019
muscle glucose increased amount, abnormal nr3c1ca401/ca401 chemical treatment by injection: D-glucose Fig. 3 from Faught et al., 2019
female organism increased weight, abnormal nr3c1ca401/ca401 standard conditions Fig. 1 from Faught et al., 2019
whole organism cortisol increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 2 from Faught et al., 2019
Fig. 2 from Faught et al., 2018
muscle L-tyrosine decreased amount, abnormal nr3c1ca401/ca401 control Fig. 7 from Faught et al., 2019
muscle L-proline increased amount, abnormal nr3c1ca401/ca401 fasting Fig. 7 from Faught et al., 2019
whole organism nr3c2 expression increased amount, abnormal nr3c1ca401/ca401 control Fig. 2 from Faught et al., 2018
whole organism decreased weight, abnormal nr3c1ca401/ca401 fasting Fig. 6 from Faught et al., 2019
blood plasma glucose decreased amount, abnormal nr3c1ca401/ca401 fasting Fig. 6 from Faught et al., 2019
adult feeding behavior decreased occurrence, abnormal nr3c1ca401/ca401 standard conditions Fig. 1 from Faught et al., 2019
whole organism hsd11b2 expression amount, ameliorated nr3c1ca401/ca401 chemical treatment by environment: cortisol Fig. 1 from Faught et al., 2018
muscle L-arginine increased amount, abnormal nr3c1ca401/ca401 fasting Fig. 7 from Faught et al., 2019
whole organism Ab2-eif4b labeling increased amount, abnormal nr3c1ca401/ca401 chemical treatment by injection: D-glucose Fig. 5 from Faught et al., 2019
whole organism hmgcs1 expression increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 3 from Faught et al., 2019
whole organism elovl2 expression increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 3 from Faught et al., 2019
whole organism star expression increased amount, abnormal nr3c1ca401/ca401 control Fig. 2 from Faught et al., 2018
muscle trim63a expression increased amount, abnormal nr3c1ca401/ca401 chemical treatment by injection: D-glucose Fig. 5 from Faught et al., 2019
muscle L-methionine increased amount, abnormal nr3c1ca401/ca401 fasting Fig. 7 from Faught et al., 2019
whole organism water decreased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 1 from Faught et al., 2019
whole organism cortisol increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 1 from Faught et al., 2019
whole organism cortisol increased amount, abnormal nr3c1ca401/ca401 stress Fig. 3 from Faught et al., 2018
whole organism cortisol increased amount, exacerbated nr3c1ca401/ca401 stress by handling Fig. 2 from Faught et al., 2019
whole organism dgat2 expression increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 3 from Faught et al., 2019
whole organism cholesterol increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 2 from Faught et al., 2019
whole organism pparg expression increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 3 from Faught et al., 2019
whole organism nr3c1 expression decreased amount, abnormal nr3c1ca401/ca401 control Fig. 2 from Faught et al., 2018
whole organism triglyceride increased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 2 from Faught et al., 2019
muscle L-tyrosine decreased amount, abnormal nr3c1ca401/ca401 fasting Fig. 7 from Faught et al., 2019
muscle L-lysine increased amount, abnormal nr3c1ca401/ca401 fasting Fig. 7 from Faught et al., 2019
blood plasma glucose amount, ameliorated nr3c1ca401/ca401 chemical treatment by injection: D-glucose Fig. 3 from Faught et al., 2019
whole organism cortisol decreased amount, abnormal nr3c1ca401/ca401 standard conditions Fig. 2 from Faught et al., 2018
whole organism glucose decreased amount, abnormal nr3c1ca401/ca401 stress by handling Fig. 2 from Faught et al., 2019
whole organism Ab5-ub labeling increased amount, abnormal nr3c1ca401/ca401 chemical treatment by injection: D-glucose Fig. 5 from Faught et al., 2019
whole organism trim63a expression decreased amount, abnormal nr3c1ca401/ca401 fasting Fig. 6 from Faught et al., 2019
muscle protein decreased amount, abnormal nr3c1ca401/ca401 fasting Fig. 6 from Faught et al., 2019
Citations